Home > News > SurgRx Secures $5 Million in Second-Round Venture Capital Financing
January 16th, 2004
SurgRx Secures $5 Million in Second-Round Venture Capital Financing
Abstract:
SurgRx, a developer of proprietary nanotechnology designed to control the delivery of electro surgical energy in vessel sealing instruments used to achieve hemostasis during surgery, announced today that it has received $5 million in second-round venture financing led by California Technology Ventures (CTV). This is the first investment in SurgRx from CTV, a leading venture capital firm specializing in early-stage companies in the information technology and life sciences marketplaces.
Source:
Businesswire
Bookmark:
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Profiles
Russia’s Nano-enabled Products Market to Witness Massive Growth February 8th, 2011
Adept Technology Announces Orders for Over $600K from Chinese Partner January 18th, 2011
Nanostart-held ItN Nanovation Receives Major Follow-on Order in Saudi Arabia November 29th, 2010
Homegrown Companies Developing Batteries for Clean Energy Storage November 2nd, 2010
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||